PARAMEDIC: mechanical vs. manual chest compressions for out of hospital cardiac arrest

Mechanical compression devices could solve manual resuscitation shortcomings and help maintain its quality. This study compared the mechanical chest compression device LUCAS-2 with manual compressions in out of hospital non traumatic cardiopulmonary resuscitation.

The study randomized 4471 patients (1652 to LUCAS-2 and 2819 to the control group) primary end point was 30 day survival and between secondary end points was return of spontaneous circulation and neurological function at 3 months. 

At 30 days, survival rates were similar in both groups (5,1% vs. 5,8%, OR 0,87, IC de 95% 0,61-1,23) even though neurological outcomes were better with manual compression (3,9 vs. 5,9%, OR 0,65, IC 95% 0,45-0,96).

Conclusion

There was no evidence of survival rate increase with mechanical resuscitation compared to manual compressions during out of hospital cardiopulmonary resuscitation. It is not possible to recommend the LUCAS-2 to replace manual compressions for routine use. 

Gavin D. Perkins
2014-11-17

Original title: Mechanical vesus manual chest compressions for Out-of-Arrest: A Cluster randomized trial. The PARAMEDIC Trial.

More articles by this author

Improved survival after out-of-hospital cardiac arrest with the use of automated external defibrillators

This study included patients presenting out of hospital cardiac arrest between 2006 and 2012 in The Netherlands to assess the impact of automated external...

Coronary flow reserve is associated to adverse events regardless angiographic severity.

This study included 329 consecutive patients derived to coronary angiography based on myocardial perfusion tests or PET scan (positron emission tomography). The extension and...

ITALIC PLUS: 6 months of double antiaggregation for no less than 24 months

Article This multicenter study included patients receiving the second generation stent XIENCE V (Abbott Vascular) randomized to 6 and 24 months of double antiaggregation therapy...

DAPT TRIAL: double antiaggregation remains controversial

Article This multicenter randomized control study with placebo was designed to determine the risks and benefits of double antiaggregation for longer than 12 months post...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...